Episode: 68 - Changing the Game of Protein-Protein Interactions With Randolph Lopez

Episode: 67 - Anthony Tolcher Discusses Oncology, Dual-Payload Technology, and the ADC Field

Episode: 66 - John Lambert on Antibody Drug Conjugates Then, Now, & Beyond

Episode 65- Tariq Ghayur on the Renaissance of Bispecifics and ADCs, AI, and More

Episode: 64 - Peyton Greenside on AI’s Role in Antibody Engineering, Optimization, and More

Episode: 63 - Discussing Protein Signaling and Structural Biology With Andrew Kruse

Episode: 62 - AI/ML in Antibody Discovery and Engineering: Reality, Hope, Future, and Hype

Episode: 61 - Tomoyuki Igawa Discusses Leadership and His Experiences in Discovery and Development

Episode: 60 - Lesley Millar-Nicholson on Technology Licensing, Navigating Patents, and Building Teams

Episode: 59 - Gabriel Rocklin on Protein Biophysics and Protein Design

Episode: 58 - Janine Schuurman Reflects on the Key Lessons and Accomplishments of Her 20-Year Career

Episode: 57 - The Future of Bispecific Antibody Drug Conjugates With Rakesh Dixit, Ph. D.

Episode: 56 - Thomas Sakmar on the Golden Age for the Application of Biologics to GPCR Pharmacology

Episode: 55 - Tala Fakhouri Discusses AI/ML for Biologics Drug Discovery & Development

Episode: 54 - Enkelejda Miho on the Current State of AI: Drug Development, Research, and the Future

Episode: 53 - Jonathan Sockolosky on Breaking Into Biotech and Making Real Progress in Ovarian Cancer Treatments

Episode 52: Entrepreneurship in Immunotherapy: Capstan’s Adrian Bot on Teambuilding

Episode: 51 - Setting the Right Strategy to Drive Engineering Parameters for Solid Tumor-Targeting T Cell-Engagers

Episode: 50 - Pivoting Research with Antibody Drug Conjugates

Episode: 49 - Building a Next Generation Bioproduction Platform